Daniel Saltiel

University of California, San Francisco

Papers

1

Total Citations

21

H-Index

1

About

Daniel Saltiel is a leading figure in radiation oncology physics, with a focused expertise in stereotactic body radiation therapy (SBRT) and treatment plan optimization for prostate cancer. His most-cited work, a 2013 study with 21 citations, tackles a critical clinical challenge: the lack of objective criteria for evaluating SBRT treatment plans. By standardizing dose constraints for prostate cancer patients treated with CyberKnife, Saltiel demonstrated how to improve both plan quality and consistency, reducing reliance on subjective physician judgment. This contribution directly addresses the difficulty of sparing organs at risk while delivering effective doses, offering a reproducible framework that enhances clinical outcomes. Beyond this landmark paper, Saltiel’s research advances the precision and reliability of radiation delivery, making him a key contributor to evidence-based radiotherapy protocols. His work is particularly valuable for students and clinicians seeking to understand how quantitative benchmarks can elevate treatment planning from an art to a science, ensuring safer and more effective care for patients undergoing SBRT.

Research Focus

Key Achievements

1
H-Index
1
Papers
21
Total Citations
21
Avg Citations/Paper
🏆 Most Cited Paper
Improving plan quality and consistency by standardization of dose constraints in prostate cancer patients treated with CyberKnife
21 citations · 2013
📈 Most Prolific Year: 2013 (1 Papers)
🤝 Key Collaborators: 10
🏛 Institutions: University of California, San Francisco

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago